Voleon Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38M Buy
295,499
+222,820
+307% +$26.1M 0.69% 22
2026
Q1
$8.74M Buy
72,679
+5,285
+8% +$610K 0.19% 121
2025
Q4
$7.09M Sell
67,394
-210,616
-76% -$19.8M 0.15% 146
2025
Q3
$23.3M Buy
278,010
+143,007
+106% +$11.8M 0.57% 25
2025
Q2
$10.7M Buy
135,003
+66,070
+96% +$5.25M 0.59% 28
2025
Q1
$6.19M Buy
68,933
+16,140
+31% +$1.51M 0.48% 59
2024
Q4
$5.25M Buy
+52,793
New +$5.44M 0.39% 71
2019
Q3
Sell
-471,600
Closed -$37.7M 211
2019
Q2
$37.7M Buy
+471,600
New +$36.1M 2.16% 14

Other funds holding MRK

Voleon Capital Management's MRK Position: Q2 2026 in Review

Voleon Capital Management increased its Merck (MRK) stake by 307% in Q2 2026, buying an estimated $26.1M and bringing the position to 295,499 shares worth $38M. The position accounts for 0.69% of the portfolio, ranked #22.

Voleon Capital Management first reported a position in MRK in Q2 2019 and has held it in 8 quarters since. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Voleon Capital Management held 295,499 shares of Merck worth $38M as of Q2 2026.
  • Voleon Capital Management bought 222,820 Merck shares in Q2 2026, an estimated $26.1M.
  • Merck made up 0.69% of Voleon Capital Management's portfolio in Q2 2026, its #22 holding.
  • Voleon Capital Management first reported a position in Merck in Q2 2019 and has held it in 8 quarters since.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.